ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 331

Development and Implementation of a Patient-Reported Outcomes Measurement Information System (MyRheum)

Chad Deal1, Abby Abelson2, Leonard H. Calabrese3, Greg Strnad4, Irene Katzan4 and M. Elaine Husni5, 1Cleveland Clinic, Shaker Heights, OH, 2Department of Rheumatologic & Immunologic Disease, Cleveland Clinic, Cleveland, OH, 3Rheumatology, Cleveland Clinic, Cleveland, OH, 4Cleveland Clinic, Cleveland, OH, 5Orthopedic and Rheumatologic Institute, Cleveland Clinic, Cleveland, OH

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: PROMIS and patient outcomes

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Measures and Measurement of Healthcare Quality Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

There is a growing recognition of the potential value for measuring patient-reported outcomes (PROs) in patients with rheumatologic conditions. PROs measured at point of care can enhance shared decision making and facilitate treatment decisions, although the ability to collect and report PROs in real time is challenging because of technology and workflow barriers. Clinical disease activity measures are important for making treatment decisions in RA but do not measure patient domains of health important to patients. The Patient-Reported Outcomes Measurement Information System (PROMIS) measures patient status for different domains in people with a wide range of diseases and scores are standardized to the US general population.

We assessed the feasibility, patient/provider compliance and utility of electronically collecting PROs in patients in a large tertiary care rheumatology practice using PROMIS Global Health (GH), PHQ9, RAPID3 or SLAQ, the PROMIS domains: pain interference, fatigue and physical function, and a review of systems (ROS).

Methods:

PROs are administered on a tablet at the patient’s visit or through the patient portal (MyChart, Epic Systems) prior to their appointment through the Knowledge Program (Cleveland Clinic, Cleveland OH), an electronic platform that is integrated within the Epic electronic health record (EHR). PROMIS domains are administered using computer adaptive testing and scores are standardized on a T scale with a mean of 50 and SD of 10. Results are displayed within the EHR at the time of the visit. The ROS is administered at every visit. PHQ9, if normal, is administered yearly and the remaining scales are completed at least 3 months apart.

Results:

Since operational (8/2016–1/2018) MyRheum has administered 100,687 questionnaires in 29,238 patients at 53,608 visits (~30% using MyChart). More than 40,000 PROMIS GH and 50,000 RAPID3 scales have been collected. PROMIS GH physical and mental health summary scores were compared across 10 Cleveland Clinic disease areas (n=276,182). Mean PROMIS physical health summary score of rheumatology patients was 42.5, worse than all disease areas (mean score range 41.1 – 49.2) except neurology. Mean mental health summary scores of rheumatology patients was 47.4, which fell in the middle of the range of mean scores of the disease areas (39.6 to 50.3). Patient completion rates averaged 71% for 2017 with a small gradual decline over time. Nearly 1/3 were collected at home prior to the visit using My Chart.

Conclusion:

The MyRheum system was successfully deployed in a tertiary care system with 27 rheumatologists in 10 locations. Cross departmental comparisons of diseases showed rheumatology patients had the second lowest self-reported physical health demonstrating the impact of our diseases and the need to measure PROs that assess this domain. The decline in participation requires further analysis. The creation of this large PRO biomarker databank demonstrates its practicality and provides a powerful platform for clinical care, research and value-based healthcare initiatives.


Disclosure: C. Deal, None; A. Abelson, None; L. H. Calabrese, None; G. Strnad, None; I. Katzan, None; M. E. Husni, None.

To cite this abstract in AMA style:

Deal C, Abelson A, Calabrese LH, Strnad G, Katzan I, Husni ME. Development and Implementation of a Patient-Reported Outcomes Measurement Information System (MyRheum) [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/development-and-implementation-of-a-patient-reported-outcomes-measurement-information-system-myrheum/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-implementation-of-a-patient-reported-outcomes-measurement-information-system-myrheum/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology